首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Effect of Xingbi Gel Nasal Drops on Fyn-STAT5 Pathway in Nasal Mucosa Fibroblasts of Guinea Pigs with Allergic Rhinitis
【24h】

Effect of Xingbi Gel Nasal Drops on Fyn-STAT5 Pathway in Nasal Mucosa Fibroblasts of Guinea Pigs with Allergic Rhinitis

机译:Xingbi凝胶鼻腔对过敏性鼻炎鼻粘膜鼻粘膜成纤维细胞Fyn-Stat5途径的影响

获取原文
       

摘要

Fyn-STAT5 is considered to be the frontier signaling pathway of IgE-mediated allergic reactions related to mast cell activation, but research on allergic rhinitis (AR) has been rarely reported. Xingbi gel nasal drops (XGND) are a compound preparation of traditional Chinese medicine, which has the exact therapeutic efficacy on AR. The current study aimed to observe the effects of XGND on Fyn-STAT5 pathway in AR guinea pig nasal mucosal fibroblasts in vitro and further illuminate the possible therapeutic mechanism of XGND on AR. The isolated and cultured nasal mucosa fibroblasts from AR guinea pigs were identified by immunocytochemical staining. Real-time PCR and western blot were performed to detect the mRNA and protein levels of the Fyn-STAT5 pathway and related cytokines in AR guinea pig nasal mucosal fibroblasts. The results indicated that XGND may interfere with the Fyn-STAT5 pathway by reducing the expression of Fyn and SCF and upregulating STAT5 and IL-10, thereby inhibiting proliferation and degranulation of mast cells, correcting Th1/Th2 immune imbalance, and then alleviating the immune response of AR fibroblasts. Our study revealed the possible regulatory mechanism of XGND in AR and laid an experimental foundation for improving the clinical efficacy of AR and enriching the clinical medication for AR.
机译:Fyn-Stat5被认为是IgE介导的与肥大细胞活化有关的过敏反应的前沿信号通路,但很少报道对过敏性鼻炎(AR)的研究。 Xingbi凝胶鼻滴(XGND)是中药的复合制备,其对AR有精确的治疗效果。目前的研究旨在观察XGND对体外Ar豚鼠鼻粘膜成纤维细胞的Fyn-Stat5途径的影响,进一步照亮XGND在Ar的可能治疗机制。通过免疫细胞化学染色来鉴定来自Ar豚鼠的分离和培养的鼻粘膜成纤维细胞。进行实时PCR和蛋白质印迹以检测Fyn-Stat5途径和相关细胞因子在AR豚鼠鼻粘膜成纤维细胞中的mRNA和蛋白质水平。结果表明,XGND可以通过减少FYN和SCF的表达和上调STAT5和IL-10的表达干扰Fyn-Stat5途径,从而抑制肥大细胞的增殖和降解,校正Th1 / Th2免疫不平衡,然后减轻免疫Ar成纤维细胞的反应。我们的研究揭示了XGND在AR中可能的调节机制,并为改善AR的临床疗效而奠定了实验基础,并富集了AR的临床用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号